Janus Henderson Group
JBIO

Janus Henderson Group’s Jade Biosciences JBIO Stock Holding History

Janus Henderson Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.6M Buy
+3,105,669
New +$45M 0.02% 442

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Janus Henderson Group's JBIO Position: Q1 2026 in Review

Janus Henderson Group opened a new position in Jade Biosciences (JBIO) in Q1 2026: 3,105,669 shares worth $43.6M. The stake represents 0.02% of the portfolio and ranks #442 among its holdings.

120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Janus Henderson Group held 3,105,669 shares of Jade Biosciences worth $43.6M as of Q1 2026.
  • Jade Biosciences was a new Janus Henderson Group position in Q1 2026.
  • Jade Biosciences made up 0.02% of Janus Henderson Group's portfolio in Q1 2026, its #442 holding.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.